Skip to main content
Curtis Schreiber, MD, Neurology, Bolivar, MO

CurtisPaulSchreiberMD

Neurology Bolivar, MO

Headache

Neurologist

Are you Dr. Schreiber?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 44 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    1245 N Butterfield Rd
    Bolivar, MO 65613
    Phone+1 417-327-3530
    Fax+1 417-327-3543

Summary

  • Dr. Curtis Schreiber, MD is a board certified neurologist in Bolivar, Missouri. He is currently licensed to practice medicine in Missouri and Minnesota. He is affiliated with Citizens Memorial Hospital.

Education & Training

  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Residency, Neurology, 1987 - 1991
  • Mayo Clinic College of Medicine
    Mayo Clinic College of MedicineClass of 1987

Certifications & Licensure

  • MO State Medical License
    MO State Medical License 1991 - 2025
  • MN State Medical License
    MN State Medical License 1988 - 1991
  • American Board of Psychiatry and Neurology Neurology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Bolivar Patients Played a Role in Clinical Trial for a Prospective Alzheimer's Treatment
    Bolivar Patients Played a Role in Clinical Trial for a Prospective Alzheimer's TreatmentMay 11th, 2023
  • Bolivar Neurologist Hopes Clinical Research Will Provide Clues About Alzheimer’s
    Bolivar Neurologist Hopes Clinical Research Will Provide Clues About Alzheimer’sJune 5th, 2020
  • Bolivar’s Citizens Memorial Hospital Part of Clinical Study for Groundbreaking Alzheimer’s Treatment Drug
    Bolivar’s Citizens Memorial Hospital Part of Clinical Study for Groundbreaking Alzheimer’s Treatment DrugJuly 21st, 2023